SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001140361-23-026989
Filing Date
2023-05-26
Accepted
2023-05-26 16:26:52
Documents
4
Period of Report
2023-05-26

Document Format Files

Seq Description Document Type Size
1 PREM14A ny20009214x1_prem14a.htm PREM14A 574549
2 FILING FEES TABLE ny20009214x1_ex107.htm EX-FILING FEES 10066
3 ny20009214x1_pc1.jpg GRAPHIC 575510
4 ny20009214x1_pc2.jpg GRAPHIC 413374
  Complete submission text file 0001140361-23-026989.txt   1946924
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-36644 | Film No.: 23969385
SIC: 2834 Pharmaceutical Preparations